Morningstar

Cigna's Evernorth to Offer Humira Biosimilar Without Out-of-Pocket Fee

Cigna Group-owned Evernorth Health Services said Thursday it would provide a Humira biosimilar with no out-of-pocket fees starting in June. The pharmacy and benefits provider said the biosimilar for ...

AbbVie's Rinvoq Beats Humira in Key Arthritis Trial

AbbVie (NYSE:ABBV) just scored a big win for its next-generation arthritis drug. The company said Monday that Rinvoq ...
Forbes

CVS Partially Dropping Top-Selling Drug Humira In Favor Of Cheaper Biosimilars

CVS Caremark, the pharmaceutical subsidiary of CVS Health, announced Wednesday it will replace AbbVie’s Humira from its list of covered drugs with cheaper alternatives for some customers—a move that’s ...
CNN

Study: Abbott s Humira Effective For Juvenile Arthritis

CHICAGO-(Dow Jones)- Humira, a drug made by Abbott Laboratories Inc. (ABT), has proven effective in treating children with juvenile rheumatoid arthritis, according to a four-year study of 171 children ...
Morningstar

AbbVie Posts Solid Q4, but Competitive Pressures to Humira and Imbruvica Limit Long-Term Growth

AbbVie reported fourth-quarter results largely in line with our expectations, and we don’t expect any major fair value estimate changes. We continue to view the stock as slightly overvalued, as we see ...

AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study

AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a ...